'Embryo bank': new hope or too far?
By Amanda Paulson,
Christian Science Monitor
| 01. 18. 2007
[Quotes CGS's Marcy Darnovsky]
In an era when infertile couples often look to test tubes or surrogate mothers to create children, the notion of egg or sperm donors is hardly novel.
Yet a San Antonio woman's idea to bring the two together - creating complete embryos ready to be implanted into the womb - has drawn a raft of criticism, with bioethicists debating whether this is the commodification of children or just another - perhaps more effective - way to help people become parents.
The "embryo bank" at the Abraham Center of Life isn't a storage bank so much as an intermediary that creates embryos from anonymous donors of both sperm and egg, for a waiting list of interested parents.
But the ethical debate around selling such embryos has called attention to the delicate balance between harnessing reproductive technology to help people achieve cherished dreams of bearing children and the danger of selective genetics in the hopes of creating "designer babies." It's also, say some critics, one more example of why more oversight is needed in a field that is advancing rapidly but has...
Related Articles
By Anna Rogers, Mother Jones | 06.19.2026
By Rebecca Simkin, BioNews | 06.29.2026
The US Food and Drug Administration (FDA) is allowing biotech company Regenxbio to reapply for licensing of a gene therapy for Hunter syndrome, in a reversal of its previous decision. Hunter syndrome, or mucopolysaccharidosis type II (MPS II), is a...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Georgia Michelman, Science | 06.18.2026